BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Soligenix 

29 Emmons Drive
Suite C-10
Princeton  New Jersey  08540  U.S.A.
Phone: 609-538-8200 Fax: 609-452-6467


SEARCH JOBS










 Company News
Soligenix (SNGX) Announces Publication Successfully Demonstrating Enhanced Immunogenicity Of Its Heat-Stable Anthrax Vaccine 1/29/2015 8:00:08 AM
FDA Grants Soligenix (SNGX) "Fast Track" Designation For SGX301 For The First-Line Treatment Of Cutaneous T-Cell Lymphoma 1/7/2015 7:34:09 AM
Soligenix (SNGX) Announces Positive Preliminary Nonclinical Results In Macrophage Activation Syndrome 1/5/2015 7:30:45 AM
Soligenix (SNGX) Announces Publication of Combination Ricin/Anthrax Vaccine Data 12/29/2014 7:38:51 AM
Soligenix (SNGX) Announces Closing Of Public Offering Of Units 12/24/2014 9:57:58 AM
Soligenix (SNGX) Announces Pricing Of Public Offering Of Units 12/19/2014 8:40:46 AM
Soligenix (SNGX) Receives $617,000 In Non-Dilutive Financing From New Jersey's Technology Business Tax Certificate Transfer Program 12/11/2014 7:19:54 AM
Soligenix (SNGX) Appoints Oreola Donini, PhD, As Chief Scientific Officer 12/10/2014 7:34:29 AM
Soligenix (SNGX) Announces Formation Of Cutaneous T-Cell Lymphoma Medical Advisory Board 11/17/2014 11:51:57 AM
Soligenix (SNGX) Reports Third Quarter 2014 Financial Results, Highlighted With The Acquisition Of SGX301, Synthetic Hypericin, For The Treatment Of Cutaneous T-Cell Lymphoma 11/10/2014 8:47:54 AM
12345678910...